Colgate-Palmolive Balance Sheet Health
Financial Health criteria checks 4/6
Colgate-Palmolive has a total shareholder equity of $836.0M and total debt of $8.4B, which brings its debt-to-equity ratio to 1009.1%. Its total assets and total liabilities are $16.8B and $15.9B respectively. Colgate-Palmolive's EBIT is $4.3B making its interest coverage ratio 18.1. It has cash and short-term investments of $1.5B.
Key information
1,009.1%
Debt to equity ratio
US$8.44b
Debt
| Interest coverage ratio | 18.1x |
| Cash | US$1.49b |
| Equity | US$836.00m |
| Total liabilities | US$15.94b |
| Total assets | US$16.77b |
Recent financial health updates
Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Dec 18
These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Recent updates
Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Dec 18Colgate-Palmolive: Digital Advertising Is The Base From Which To Start Again
Dec 17Colgate-Palmolive: Approaching Buy Territory With Some Important Catalysts
Dec 11Colgate-Palmolive Company's (NYSE:CL) Share Price Not Quite Adding Up
Dec 03Colgate-Palmolive Company's (NYSE:CL) Intrinsic Value Is Potentially 63% Above Its Share Price
Nov 20If EPS Growth Is Important To You, Colgate-Palmolive (NYSE:CL) Presents An Opportunity
Oct 26Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now
Oct 25Colgate-Palmolive: Very Close To A Buy Following Recent Pullback
Oct 17Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)
Sep 30These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down
Aug 27Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Aug 19An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued
Aug 12Colgate-Palmolive: Good Growth Prospects Ahead
Aug 06Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)
Jul 11Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings
Jul 10Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite
Jun 23Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital
May 21Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report
Apr 30Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Colgate-Palmolive: Dividend King With Limited Growth
Sep 27Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive: Challenging Growth Prospects
Jul 10Financial Position Analysis
Short Term Liabilities: CL's short term assets ($5.8B) exceed its short term liabilities ($5.6B).
Long Term Liabilities: CL's short term assets ($5.8B) do not cover its long term liabilities ($10.4B).
Debt to Equity History and Analysis
Debt Level: CL's net debt to equity ratio (830.4%) is considered high.
Reducing Debt: CL's debt to equity ratio has reduced from 4684.5% to 1009.1% over the past 5 years.
Debt Coverage: CL's debt is well covered by operating cash flow (47.1%).
Interest Coverage: CL's interest payments on its debt are well covered by EBIT (18.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 23:37 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Colgate-Palmolive Company is covered by 54 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christopher Graja | Argus Research Company |
| Edward Lewis | Atlantic Equities LLP |
| Ishan Majumdar | Baptista Research |